OMARON (Fezam, Piratsezin, Combo: Piracetam & Cinnarizine) nootropic drug which contains a combination of piracetam and cinnarizine. It is a combined drug having antihypoxic (body oxygen flow increase), nootropic and vasodilatory (body bloodflow improvement) effect. Omaron is extensively used for treatment of cognitive impairment. The drug increases glucose and oxygen consumption in brain cells which precedes cognitive improvement.
GUARANTEE & EXPIRY DATE
100% Original from the Russian OJSC NizhPharm (part of STADA CIS Group).
All packs are air tight sealed and expire up to 02.2022.
Piracetam increases brain oxygen consumption and antagonizes an inhibition of glucose uptake into erythrocytes. Piracetam improves regional blood flow in ischemic areas of the brain. Cinnarizine is a selective inhibitor of slow calcium channels, inhibits the flow of calcium ions across the membranes of smooth muscle cells. Cinnarizine increases flexibility of red blood cell membranes.
Omaron - is a registered trademark of STADA Arzneimittel AG, Germany.
Further read: http://www.ncbi.nlm.nih.gov/pubmed/20559275
PACKAGING & DOSAGE
One pack contains 60 pills of 425mg each, 400mg piracetam and 25mg cinnarizine
To be taken orally with or after meal.
Dosage for adults:
1-2 tablets 3 times a day. The period of treatment is 1-3 months depending on the severity of condition.
Dosage for pediatric patients:
5 years old and over: 1-2 tablets 1-2 times a day.
Dosage for patients with renal disorder (kidney failure):
1 tablet 2 times a day.
Omaron is considered to be car driving safe. Do not consume with alcohol.
The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications.
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celsius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about Omaron.
|The purpose of the medication||Nervous System Treatment|